Ambu A S (AMBBY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 14 62 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- +10.4% close of June 25, 2026
- 1-year change
- +8.3% closing prices, November 5, 2025 to November 5, 2026
- 1-month change
- +23.6% closing prices, September 30, 2026 to November 5, 2026
Company Description
Ambu A S (OTC: AMBBY) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $3.5B.
AMBBY has gained 8.3% over the past year. The last closing price was $13.60.
This page collects what Stock Titan holds for AMBBY, including price data, latest news, and short interest trends.
Stock Performance
Ambu A S (AMBBY) closed at $13.60 on November 5, 2026. Over the past 12 months, the price has gained 8.3%.
AMBBY Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Ambu A S has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include management. View all AMBBY news →
SEC Filings
Short Interest History
Short interest in Ambu A S (AMBBY) currently stands at 390 shares, up 333.3% from the previous reporting period, representing 0.0% of the shares outstanding. Since December 2025, short interest has decreased by 28.7%.
Days to Cover History
Days to cover for Ambu A S (AMBBY) currently stands at 20.5 days, up 1953% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since December 2025, the figure has increased by 788.7%. Across the settlements charted above, it has ranged from 1.0 to 20.5 days.
AMBBY Company Profile & Sector Positioning
Ambu A S (AMBBY) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing AMBBY often look at related companies in the same sector, including GN Store Nord A/S (GNNDY), Elekta (EKTAY), Elekta (EKTAF), Cochlear plc (CHEOY), and Getinge AB (GNGBY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AMBBY's relative position within its industry.